Mestra Pharma Pvt Ltd
Levosulpiride (75mg) + Esomeprazole (40mg)
Meozole L Capsule SR 75mg/40mg is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Meozole L Capsule SR 75mg/40mg is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Meozole L Capsule SR 75mg/40mg is to be taken empty stomach.
Meozole L Capsule SR 75mg/40mg is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Meozole L Capsule SR 75mg/40mg as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Meozole L Capsule SR 75mg/40mg for longer than prescribed.
Store Meozole L Capsule SR 75mg/40mg in its original container, tightly closed, according to the instructions on the pack or label. Dispose of any unused medication, ensuring it is not accessible to pets, children, or other individuals.
Take Meozole L Capsule SR 75mg/40mg exactly as directed by your doctor. It is generally recommended to take one capsule daily on an empty stomach.
Meozole L Capsule SR 75mg/40mg should be avoided in patients with a known allergy to any component or excipient of this medication.
Yes, Meozole L Capsule SR 75mg/40mg may cause dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. If you experience dizziness or lightheadedness, it is recommended to rest for a while and resume once you feel better.
Several studies in adults suggest that treatment with Meozole L Capsule SR 75mg/40mg may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. This increased risk is more pronounced in patients who receive high doses (multiple daily doses) and long-term therapy (a year or longer).